For the year ending 2025-12-31, JXN has $352,586M in assets. $342,244M in debts. $5,704M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Debt securities, available-for-sale, net of allowance for credit losses of 11 and 39 at december31, 2025 and 2024, respectively (amortized cost 2025 50,491 2024 45,007) | 47,321 | |||
| Debt securities, at fair value under fair value option | 3,470 | |||
| Equity securities, at fair value | 172 | |||
| Mortgage loans, net of allowance for credit losses of 133 and 121 at december31, 2025 and 2024, respectively | 9,887 | |||
| Mortgage loans, at fair value under fair value option | 324 | |||
| Policy loans (including 3,537 and 3,489 at fair value under the fair value option at december31, 2025 and 2024, respectively) | 4,426 | |||
| Freestanding derivative instruments | 448 | |||
| Other invested assets | 3,185 | |||
| Total investments | 69,233 | |||
| Cash and cash equivalents | 5,704 | |||
| Accrued investment income | 634 | |||
| Deferred acquisition costs | 11,660 | |||
| Reinsurance recoverable, net of allowance for credit losses of 30 and 27 at december31, 2025 and 2024, respectively | 19,518 | |||
| Reinsurance recoverable on market risk benefits, at fair value | 118 | |||
| Market risk benefit assets, at fair value | 7,867 | |||
| Deferred income taxes, net | 719 | |||
| Other assets | 637 | |||
| Separate account assets | 236,496 | |||
| Total assets | 352,586 | |||
| Reserves for future policy benefits and claims payable | 10,896 | |||
| Other contract holder funds | 67,663 | |||
| Market risk benefit liabilities, at fair value | 3,754 | |||
| Funds withheld payable under reinsurance treaties (including 3,723 and 3,667 at fair value under the fair value option at december31, 2025 and 2024, respectively) | 14,960 | |||
| Long-term debt | 2,030 | |||
| Repurchase agreements and securities lending payable | 1,036 | |||
| Collateral payable for derivative instruments | 58 | |||
| Freestanding derivative instruments-Freestanding Derivative | 257 | |||
| Other liabilities-Related Party | 2,578 | |||
| Other liabilities-Nonrelated Party | 2,516 | |||
| Separate account liabilities | 236,496 | |||
| Total liabilities | 342,244 | |||
| Series a non-cumulative preferred stock and additional paid in capital, 1.00 par value per share 24,000 shares authorized 22,000 shares issued and outstanding at december31, 2025 and december31, 2024 liquidation preference 25,000 per share (see note 23) | 533 | |||
| Common stock 1,000,000,000 shares authorized, 0.01 par value per share and 66,825,632 and 73,380,643 shares issued and outstanding at december31, 2025 and december31, 2024, respectively (see note 23) | 1 | |||
| Additional paid-in capital | 6,063 | |||
| Treasury stock, at cost 27,662,683 and 21,107,672 shares at december31, 2025 and 2024, respectively | 1,645 | |||
| Accumulated other comprehensive income (loss), net of tax expense (benefit) of (377) in 2025 and (311) in 2024 | -2,470 | |||
| Retained earnings | 7,471 | |||
| Total shareholders' equity | 9,953 | |||
| Noncontrolling interests | 389 | |||
| Total equity | 10,342 | |||
| Total liabilities and equity | 352,586 | |||
Jackson Financial Inc. (JXN)
Jackson Financial Inc. (JXN)